Infant formula additive with potential gut benefits, call for comment
Food Standards Australia New Zealand (FSANZ) is calling for comment on an application to permit the use of a nutritive substance in infant formula products.
The substance, 3-fucosyllactose (3-FL), is a type of human-identical milk oligosaccharide (HiMO) made using a genetically modified source organism.
The application made by Glycom A/S seeks approval to use the synthesised 3-FL in infant formula products. FSANZ has found it is chemically, structurally and functionally the same as the naturally occurring 3-FL found in human milk.
3-FL offers potential health benefits for infants including increasing beneficial gut bacteria, such as Bifidobacterium, and anti-pathogenic effects.
FSANZ’s safety assessment found no public health or safety concerns with the proposed use. While breastfeeding is recommended, a safe and nutritious substitute for breast milk is needed for infants who are not breastfed.
All commercially produced infant formula products available in Australia must comply with the composition and safety requirements outlined in the Australia New Zealand Food Standards Code.
These standards apply in Australia only. The New Zealand Government is responsible for maintaining infant formula product regulations in New Zealand.
Submissions close at 11:59 pm (Canberra time) Wednesday, 23 July 2025.
To find out more, visit here.
Seprify and BIOGRUND develop titanium dioxide-free tablet coating for nutraceuticals
BIOGRUND partners with Seprify to bring a clean-label nutraceutical tablet coating to market.
Health claim secured for soy protein in Australia and NZ
IFF announced it has secured FSANZ approval which allows food manufacturers to link soy protein...
Cocoa-free ingredient supplier scales up production
An Italian foodtech company has raised funding to help it expand and scale production of its...
